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DEAR EDITOR, A 23-month-old female presented with abnormal
cutaneous pigmentation since birth. She had a past history of
mediastinal non-Hodgkin lymphoma diagnosed at 9 months
of age and treated with surgery and chemotherapy. Family
history revealed her grandfathers were brothers, and both died
of colon cancer in their fifth decade. Her parents were both fit
and well in their early 30s.
The patient had Fitzpatrick skin type IV, with 10 cafe au lait
macules of up to 10 cm in diameter, and six hypomelanotic
macules of 05–1 cm. In addition, she had extensive atypical
dermal melanocytosis, with multiple blue-grey macules pre-
dominantly on her back, of 1–10 cm, with an irregular out-
line (Fig. 1). The remainder of her physical examination was
normal. A clinical diagnosis of constitutional mismatch repair
deficiency syndrome (CMMRD) was made.
Interphase fluorescence in situ hybridization revealed a nor-
mal germline female karyotype with no chromosomal rear-
rangements. Next-generation sequencing (NGS) of leukocyte
DNA of the mismatch repair genes MLH1, MSH2 and MSH6
revealed a novel homozygous mutation in MSH6
(c.3934_3937dupGTTA, p.(Ile1313SerfsTer7)) predicted to be
pathogenic, confirming the clinical diagnosis. Both parents
were confirmed to be heterozygous for the same mutation. As
somatic mutations in GNA11 and GNAQ can be a cause of
extensive or atypical dermal melanocytosis, DNA was extracted
directly from a skin biopsy of an area of dermal melanocyto-
sis. Targeted NGS of mutation hotspots (codons 183 and 209)
revealed wild-type sequence, excluding these as a cause of this
aspect of the phenotype.
Mismatch repair is a critical mechanism during DNA repli-
cation for maintenance of genome integrity. Mutations in mis-
match repair (MMR) genes MLH1, MSH2, MSH6 or PMS2 result
in increased cancer susceptibility. Lynch syndrome, or heredi-
tary nonpolyposis colorectal cancer, results from monoallelic
(heterozygous) germline mutations in MMR genes. This auto-
somal dominant cancer predisposition syndrome is character-
ized by colorectal, endometrial, ovarian, gastric, small
intestinal or urinary tract cancers from early adulthood.
Tumorigenesis results from loss of the remaining MMR gene
wild-type alleles and accumulation of further mutations in
cancer genes.
CMMRD is a rare autosomal recessive disease resulting from
biallelic germline mutations, either homozygous or compound
heterozygous, in one of the four mismatch repair genes. It can
also be known as biallelic mismatch repair disorder
(BMMRD), highlighting that a history of consanguinity is an
important early diagnostic clue,1 as there may not be a strik-
ing family history of cancers in the extended family.1 It was
first reported in 1999, and over 100 cases have been reported
to date.2 In contrast to Lynch syndrome, which presents with
cancers from the fourth decade, patients with biallelic MMR
gene mutations develop a diverse spectrum of childhood
malignancies, and often multiple malignancies, in early life.
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Fig 1. Dermal melanocytosis, hyperpigmentation and hypopigmentation in a 23-month-old female with constitutional mismatch repair deficiency
syndrome (a). Blue-grey macules of dermal melanocytosis were seen with irregular, ragged edges (b, c). Widespread hyperpigmented macules,
again with ragged edges, were present with one large clearly defined cafe au lait macule (d).
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malignancies predominate.3,4 In the first 15 years of life, CNS
tumours are the most frequently observed malignancies, the
majority being high-grade gliomas.4 Haematological malig-
nancies are also frequently seen, of which the most common
is non-Hodgkin lymphoma. Non-Hodgkin lymphoma and
acute leukaemia are the earliest observed malignancies in
CMMRD, presenting as early as 4 months of age.4
The skin offers valuable diagnostic clues in many DNA repair
disorders. Cafe au lait macules are a recognized feature of
CMMRD frequently causing diagnostic confusion with neurofi-
bromatosis (NF)1. Unlike the cafe au lait macules observed in
NF1, which have clearly defined borders, hyperpigmented mac-
ules in CMMRD often have ragged borders. Wimmer et al., in the
largest comprehensive review of all published cases of CMMRD,
described hyperpigmentation in 91 of 146 cases.4 Hypopigmen-
tation was observed in nine of 146 patients. Other cutaneous fea-
tures include so-called ‘haemangiomas’ without further
description reported in two cases5,6 and sebaceous cysts in one.7
We reviewed all 43 published cases of biallelic MSH6 muta-
tions with regard to their cutaneous phenotype (Table S1; see
Supporting Information). Hyperpigmentation was observed in
39 of 40 patients, and axillary freckling in four of 40; therefore
patients can sometimes meet the diagnostic criteria for NF1.
Hypopigmentation was reported in six of 40 patients; however,
this may be due to under-reporting as in the authors’ experience
this is a near universal finding in clinical practice.
Extensive or a typical dermal melanocytosis, as seen in this
case, has not yet been described in CMMRD. However, exami-
nation of clinical images from other published case reports
revealed dermal melanocytosis in a further case.8 Additionally,
in 1998, prior to the first description of CMMRD, one of the
authors reported a case of suspected NF1 in a child with atyp-
ical dermal melanocytosis, ocular melanosis and cafe au lait
macules, who had developed non-Hodgkin lymphoma. In
hindsight we believe that a diagnosis of CMMRD is likely.9
Dermal melanocytosis is common in the general population in
the form of Mongolian blue spots, and has been shown to be
under-reported by clinicians.10 We hypothesize that it may be
an under-reported feature in CMMRD.
This case highlights the early diagnostic clues offered by
thorough cutaneous examination in CMMRD. Clinicians
should be alert to the diverse range of pigmentary abnormali-
ties observed in CMMRD, so as to prompt consideration of
this diagnosis in cases presenting with dyspigmentation with
an appropriate family or personal history of malignancy or a
history of consanguinity. Early diagnosis can then lead to the
implementation of screening for malignancies in both the pro-
band and the wider family.1
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